6998 fundamentals
An in-depth look to GENOR BIOPHARMA HLDGS LTD operating, investing, and financing activities
6998 free cash flow for H1 24 is -160.16 M HKD. For 2023, 6998 free cash flow was -470.9 M HKD and operating cash flow was -469.76 M HKD.
Q1 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q1 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM